All data are based on the daily closing price as of August 12, 2025
s
Shinpoong Pharm
019170.KO
9.49 USD
0.29
+3.15%
Overview
Last close
9.49 usd
Market cap
467.52M usd
52 week high
14.06 usd
52 week low
4.50 usd
Target price
4.15 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.9186
Price/Book Value
2.5806
Enterprise Value
471.58M usd
EV/Revenue
2.944
EV/EBITDA
377.8615
Key financials
Revenue TTM
160.18M usd
Gross Profit TTM
60.17M usd
EBITDA TTM
-2.56M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
228.62M usd
Net debt
N/A usd
About
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.